[go: up one dir, main page]

AR050805A1 - Metodos y medios para producir hialuronano - Google Patents

Metodos y medios para producir hialuronano

Info

Publication number
AR050805A1
AR050805A1 ARP050104013A AR050805A1 AR 050805 A1 AR050805 A1 AR 050805A1 AR P050104013 A ARP050104013 A AR P050104013A AR 050805 A1 AR050805 A1 AR 050805A1
Authority
AR
Argentina
Prior art keywords
methods
hyaluronan
hialuronan
produce
plants
Prior art date
Application number
Other languages
English (en)
Original Assignee
Bayer Cropscience Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Gmbh filed Critical Bayer Cropscience Gmbh
Publication of AR050805A1 publication Critical patent/AR050805A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C12N15/8246—Non-starch polysaccharides, e.g. cellulose, fructans, levans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente se refiere a células de palntas y a aplantas que sintetizan hialuronano y a métodos para preparar tales plantas, y también a métodos para preparar hialuronano con la ayuda de tales células de plantas o plantas. Además, la presente invencion se refiere al uso de plantas para preparar hialuronano y a productos alimenticios o forraje que comprende hialuronano.
ARP050104013 2004-09-23 2005-09-26 Metodos y medios para producir hialuronano AR050805A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04090373A EP1640457A1 (de) 2004-09-23 2004-09-23 Verfahren und Mittel zur Herstellung von Hyaluronan

Publications (1)

Publication Number Publication Date
AR050805A1 true AR050805A1 (es) 2006-11-22

Family

ID=34928827

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104013 AR050805A1 (es) 2004-09-23 2005-09-26 Metodos y medios para producir hialuronano

Country Status (3)

Country Link
EP (1) EP1640457A1 (es)
CN (1) CN101027399B (es)
AR (1) AR050805A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1951878E (pt) * 2005-10-05 2015-06-08 Bayer Ip Gmbh Plantas com produção de hialurano aumentada
AU2006298961B2 (en) * 2005-10-05 2013-05-02 Bayer Intellectual Property Gmbh Plants with increased hyaluronan production
EP2140009A2 (en) * 2007-03-29 2010-01-06 CBD Technologies Ltd. Transgenic plants containing soluble cell wall polysaccharides
EP2036983A1 (de) * 2007-09-12 2009-03-18 Bayer CropScience AG Pflanzen, die erhöhte Mengen an Glucosaminglycanen synthetisieren
CN103937734B (zh) * 2014-04-23 2016-05-11 清华大学 一种生产透明质酸的基因工程菌及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401806D0 (sv) * 1994-05-26 1994-05-26 Pharmacia Ab Method and means for the production of hyaluronic acid
JP4731013B2 (ja) * 1997-10-31 2011-07-20 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ オクラホマ ヒアルロナンシンターゼ遺伝子およびその使用
BR0215220A (pt) * 2001-12-21 2007-01-09 Novozymes Biopolymer As método para produzir um ácido hialurÈnico, célula hospedeira de bacillus, construção de ácido nucléico, seqüência de ácido nucléico isolada, vetor de expressão , vetor de expressão recombinante, célula hospedeira recombinante, método para produzir um polipeptìdeo, e, polipeptìdeo isolado
CN1498626A (zh) * 2002-11-04 2004-05-26 张晓崧 透明质酸在提高人体免疫力、改善免疫力缺乏症状方面的应用

Also Published As

Publication number Publication date
EP1640457A1 (de) 2006-03-29
CN101027399B (zh) 2012-02-08
CN101027399A (zh) 2007-08-29

Similar Documents

Publication Publication Date Title
CO2021005364A2 (es) Un proceso para elaborar un producto análogo de carne
CL2011002083A1 (es) Preparado proteico a partir de semillas de colza, con contenido de proteinas menor a 90%, en que el preparado tiene funcionalidad ligadora de agua, ligadora de aceite y emulsionante; procedimiento de obtencion del preparado proteico; su uso; y procedimiento de utilizacion energetica de las cascaras.
CU20150127A7 (es) Unidad para liberación de agroquímicos en las raíces de una planta y métodos de uso
MX2009003521A (es) Uso de ph bajo para modificar la textura de productos de proteina vegetal estructurada.
TR201809592T4 (tr) Aktif içerik maddelerinin bileşimleri.
BR112013017382A2 (pt) métodos para preparação de glicoesfingolipídios e usos destes
CL2008000526A1 (es) Producto de confiteria congelado que comprende inclusiones de suero proteico; porcion individual del producto; uso de inclusiones de suero proteico; procedimiento de elaboracion de productos de confiteria congelados; procedimiento para mejorar el niv
BRPI0307155A8 (pt) plantas transgênicas expressando proteínas modificadas por civps ou inteínas e método relativo
MX2009005313A (es) Uso de productos de proteina vegetal estructurada para producir productos carnicos emulsionados.
MA33955B1 (fr) Utilisation d'un métabolite naturel pour accroitre la production végétale.
ITMI20041820A1 (it) Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico.
CR20140557A (es) Evento de maíz mon 87411
CL2012003075A1 (es) Composicion farmaceutica en solucion de pazopanib, estable y para uso oftalmico; metodo para la preparacion de dicha solucion.
EA200702586A1 (ru) Кристаллические модификации пираклостробина
BRPI0800853A2 (pt) concentrado embalado, processo para preparaÇço de um concentrado embalado e uso de um concentrado embalado
CO2019008103A2 (es) Composiciones farmacéuticas para terapia de combinación
CL2012000508A1 (es) Composicion para la aplicacion en cultivos agricolas al aire libre o invernaderos que comprende zeolita, y aditivos; uso de la composicion para aumentar el rendimiento de los cultivos agricolas.
BRPI0800365A2 (pt) cápsula, método para preparar uma cápsula, método de embalamento de material biológico de origem vegetal em cápsula, métodos de cultivo de cultura e uso de cápsula
BRPI0801060A2 (pt) concentrado embalado, processo para preparaÇço de um concentrado embalado e uso de um concentrado
BR112013020841B8 (pt) Processo para preparar produtos que compreendem ativos estabilizados e composições que compreendem os mesmos
UY31758A (es) Forma cristalina anhidra de maleato de orvepitant
WO2009153378A3 (es) Sistema en continuo de transformación de co2 en productos de alto valor añadido y/o nutricional y otros recursos energéticos
AR056313A1 (es) Inulina de cadena larga
WO2010119424A3 (fr) Composition destinee a la regulation du metabolisme des lipides
BR112013028607A2 (pt) composições sólidas contendo éter glicólico e água

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee